Join to View Full Profile
Nihnida Bayview CampusBRC 251 Bayview Boulevard Room 01a844Baltimore, MD 21224
Phone+1 443-740-2801
Dr. Leggio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Cattolica del Sacro CuoreClass of 2003
Certifications & Licensure
MD State Medical License 2014 - 2026
Publications & Presentations
PubMed
- GLP-1 receptor agonists in alcohol use disorder and alcohol-associated liver disease.Ashwani K Singal, Lorenzo Leggio
The Lancet. Gastroenterology & Hepatology. 2025-08-01 - 17 citationsNew insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease.Luis Antonio Diaz, Gerald Scott Winder, Lorenzo Leggio, Jasmohan S Bajaj, Ramon Bataller
Hepatology. 2025-07-01 - 5 citationsManagement of alcohol use disorder: a gastroenterology and hepatology-focused perspective.Luis Antonio Díaz, Daniel König, Sabine Weber, Gustavo Ayares, José Miguel Fuentealba
The Lancet. Gastroenterology & Hepatology. 2025-05-01
Press Mentions
Ozempic Users Are Seeing a Surprising Drop in Alcohol and Drug CravingsJune 29th, 2025- Can Weight Loss Drugs Help You Cut Back on Drinking? A New Study Shows Their Effect on Alcohol CravingsFebruary 14th, 2025
- Ozempic Shows Promise in Reducing Alcohol Consumption in First TrialFebruary 13th, 2025
- Join now to see all
Grant Support
- Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)NATIONAL INSTITUTE ON DRUG ABUSEPresent
- Office of the Clinical DirectorNATIONAL INSTITUTE ON DRUG ABUSEPresent
- Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.NATIONAL INSTITUTE ON DRUG ABUSEPresent
- Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.NATIONAL INSTITUTE ON DRUG ABUSEPresent
- NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical ProgramNATIONAL INSTITUTE ON DRUG ABUSEPresent
- Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.NATIONAL INSTITUTE ON DRUG ABUSEPresent
- Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)NATIONAL INSTITUTE ON DRUG ABUSEPresent
- Office of the Clinical DirectorNATIONAL INSTITUTE ON DRUG ABUSEPresent
- NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical ProgramNATIONAL INSTITUTE ON DRUG ABUSEPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
